Nektar Therapeutics (NKTR) Current Deferred Revenue (2010 - 2020)
Nektar Therapeutics (NKTR) reported Current Deferred Revenue of $91,000 for Q4 2020, down 98.4% from $5.52 million a year earlier and down 82.1% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Current Deferred Revenue (2010 - 2020) Analysis & Trends
Dating back to Q4 2010, Nektar Therapeutics' Current Deferred Revenue record includes 40 quarters.
- Current Deferred Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -66.5% (FY2015 to FY2020).
- By year, Current Deferred Revenue came in at $5.52 million in FY2019 (-60.3%), $13.89 million in FY2018 (-26.7%), $18.95 million in FY2017 (+32.0%) and $14.35 million in FY2016 (-33.0%).
- The Q4 2020 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- Year over year, Current Deferred Revenue has now declined in each of the last ten quarters, with an average decline of 67.8% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q3 2017 (growth of 80.8%); the low point was Q4 2020 (a decline of 98.4%).
- Per Business Quant data, the three quarters before Q4 2020 came in at $507,000 (Q3 2020), $1.76 million (Q2 2020) and $3.01 million (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Nektar Therapeutics | 1.25 Bn | -515.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 91,000.00 |
| Sep 30, 2020 | 507,000.00 |
| Jun 30, 2020 | 1.76 Mn |
| Mar 31, 2020 | 3.01 Mn |
| Dec 31, 2019 | 5.52 Mn |
| Sep 30, 2019 | 8.40 Mn |
| Jun 30, 2019 | 9.90 Mn |
| Mar 31, 2019 | 11.09 Mn |
| Dec 31, 2018 | 13.89 Mn |
| Sep 30, 2018 | 15.68 Mn |
| Jun 30, 2018 | 17.99 Mn |
| Mar 31, 2018 | 19.53 Mn |
| Dec 31, 2017 | 18.95 Mn |
| Sep 30, 2017 | 25.49 Mn |
| Jun 30, 2017 | 13.37 Mn |
| Mar 31, 2017 | 24.19 Mn |
| Dec 31, 2016 | 14.35 Mn |
| Sep 30, 2016 | 14.10 Mn |
| Jun 30, 2016 | 16.02 Mn |
| Mar 31, 2016 | 17.24 Mn |
API Access
Nektar Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();